BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida FDA takes first step in possible reversal of ban on some peptides The Washington Post Know Your Source: Protecting Patients from Unsafe Drugs FDA Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences